title: Presurgical progesterone in early breast cancer: so much for so little?
authors.forename: Mitch
authors.initials: M
authors.lastname: Dowsett
authors.forename: Ian E
authors.initials: IE
authors.lastname: Smith
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003692:Delayed-Action Preparations; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage*; D007273:Injections, Intramuscular; D008207:Lymphatic Metastasis; D008408:Mastectomy / Q000401:mortality*; D008597:Menstrual Cycle / Q000187:drug effects*; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018579:Patient Selection; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D003692:Delayed-Action Preparations; D006908:Hydroxyprogesterones